Welcome to article directory Cancer Lung Mesothelioma Asbestos . Here You can find interesting and useful information on most popular themes.

There are 230 published articles and 382 registered authors in our article directory.

Recent Articles

Cell Phone Privacy Lawsuit Information

By admin | Published January 26, 2012

Cell Phone Privacy Lawsuit News- 1/25/2012: Increasingly, cell phone calls and computer communications, whether over personal computer, laptop, or handheld device with multiple functionality, are being transmitted over the Internet in a wireless form, giving users greater mobility and allowing them to work, socialize, and interact with others anyplace where there is wireless service available. Work is no longer confined to the office, playing games can take place alone or with anonymous participants in cyberspace, and daily life can incorporate multiple functions from different locations. For many, the typical nine-to-five workday is becoming a distant memory, and the types of activities formerly associated with “home,” “work,” and “leisure” are no longer clearly separated. There is some irony in thinking that using cell phones and the Internet gives us more flexibility about where we go and how we control our time, but at the same time, many people report that they feel more stress in their lives, rather than less. Could these two technologies be contributing to more stress, rather than simplifying or facilitating our lives?

Everyone has a strong opinion about cell phones. Many people complain that the cell phone is an annoyance, but then claim they couldn’t live without one. The cell phone is not just a more portable version of our traditional wired telephone. It is a small, portable technology that allows us to make phone calls and participate in a wide range of media interactions anywhere, anytime (as long as we’re in range of a cell tower). It is actually remarkable that in a period of about ten years, cell phones have become a “must-have” technology for many, despite the often-poor reception quality or unreliability of cell phones, the need to remember to charge them, and their extra cost. In the United States, where 92.9 percent of the population already has access to a telephone,1 the growth of the less reliable and more expensive cell phone is nothing short of a phenomenon.

The Internet became a viable form of communication as early as the 1960s, but the commercial explosion of home-based Internet use started in the early 1990s. Like many technologies that seem to become second nature to a segment of the population, the Internet has developed to provide a host ofservices that may have been already available to people in other ways before they found their way to the online world. Many people, particularly the younger members of our society, spend hours each day negotiating the world of the Internet—time they are not spending with other forms of media or with other people. Google’s acquisition of the popular Internet site YouTube, on which anyone can post video clips, made headlines in October 2006 because of the $1.65 billion (in stock) purchase price. Within two months, Verizon, Fox, CBS, and NBC announced that they, too, were collaborating on offering an Internet alternative to YouTube.5 The television and film industries know that they’ve got to court the Internet crowd or lose valuable viewers of traditional media content.

For more information on Cell Phone Privacy Lawsuit: follow us on our RSS Feeds.

Personal habits also condition people to use communication technologies in particular ways. Checking cell phone messages or answering e-mail first thing in the morning is now as much of a routine for many as having a cup of coffee or brushing your teeth. Getting news or music over the Internet is convenient and can be done while sending e-mail, reading the latest celebrity gossip, or working from home, all over the Internet. Who your “friends” are can be listed in an available directory on a cell phone or on any number of personal social networking sites on the Internet. When a cell phone is programmed to block calls from anyone who hasn’t been entered into an “approved” call list, or someone removes your name from their roster of “friends,” the number of interactions on either technology are limited. There is no surprise that many people claim that the more we have access to communication technologies, the less we really communicate.

Sometimes cell phones and the Internet are the catalysts for social change, and sometimes they reflect social change: either way, these technologies are contributing to subtle changes in American values and to how different groups (based on age, gender, class, and race) use those changes to define individual and group identities. This book is about the changes that cell phones and the Internet—the dynamic duo—are bringing to American life, where the technologies always seem to be “on.” As a cultural history, this book examines how these two technologies—separately and together—are contributing to a change in American attitudes, behaviors, and cultural values.

It is probably human nature to want to believe that all technologies make our lives easier, better, or more efficient. After all, commercials for these products and services promise us better control over the chaos of our lives. When we first start using a new technology, we experience a learning curve. For those who learn quickly, expectations for what the technology can do for us can be wonderful. Those who struggle to learn how to use the technology may experience greater stress or anxiety. Some people try something, only to realize that they don’t really like or need it. But those who do master the technology tend not to notice how they begin to rely on it. The instantaneous nature of communicating with cell phones and the Internet leads us to transmit and receive information faster and with less consideration for how it might affect our lives. Our ability to connect immediately, anywhere, anytime, to someone conditions us to think of all activities in full operation twenty-four hours a day, seven days a week. That hum we feel in the air may be constant, invisible potential for immediacy—or it may well be anxiety, particularly for those who allow these technologies to infiltrate so many aspects of daily life. Or, it may accompany the unspoken reality that our daily activities, both private and public, are changing our culture in ways that we don’t yet truly understand, and for that reason, we feel uncomfortable.

Information from other sources on Cell Phone Privacy Lawsuit:

Earlier technologies give us a clue to understanding social change. The telegraph and telephone changed American culture; they united east and west coasts with a distribution form that delivered communication and messages to people and changed the way they lived, worked, and played. The wired model of communi­cation became the backbone for telephony and the Internet, and even though we increasingly use these technologies in wireless form, the institutions, practices, and social attitudes about communication remain rooted in the structures that intro­duced wired communications to American culture in the late nineteenth century and all of the twentieth.

Our use of the term or terms Cell Phone Privacy Lawsuit: is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Cell Phone Privacy Lawsuit: visit our site often.

Cell Phone Privacy Lawsuit

Posted in Cancer Lung Mesothelioma Asbestos | Tagged , |

Mesothelioma Cancer Data

By admin | Published January 26, 2012

Mesothelioma Cancer : The doctor may also request an MRI (magnetic reso­nance image). An MRI uses radio waves and strong magnets along with a computer to form detailed images of the body. The MRI can occasionally give the doctor information about whether the diaphragm or chest wall have become involved and if the tumor has invaded through it. Not all mesothelioma specialists use MRIs in their workup. A PET scan (positron emission tomography scan) is a relatively new type of scan that shows how the body takes up and uses glucose (sugar). Tumors, cancer cells, and areas that are inflamed or infected use glucose at a higher rate than normal tissues do. Since a radioactive tracer is attached to the glucose injected into your body, the areas which use glucose at a higher rate (i.e. tumors) will hold onto the radioactive tracer longer than normal cells. Areas on PET scans that “light up” as bright spots are abnormal. It is important to know, however, that abnormal areas on PET scans are not necessarily cancerous; they can also be the result of inflammation. The PET scan can also give the doctor information as to whether the cancer has spread outside the original area to other parts of the body, and it may pick up areas of spread that are completely unexpected. Mesothelioma Cancer

For more information on Mesothelioma Cancer follow us on our RSS Feeds.

There have not been enough large studies that prove the usefulness of this scan in mesothelioma, and therefore it has not been approved by most insurance companies as a standard test for mesothelioma, as it has been for lung cancer. However, there are mechanisms that can help pay for PET scans that doctors who do them (nuclear medicine physicians) can help you with. Ask them about these programs. A patient with a large, unexplained fluid accumulation in the chest or abdomen and who has a small or moder­ate amount of thickening of the pleura should have a biopsy performed, using semi-invasive techniques (tech­niques that require only local anesthesia and that do not involve cutting into the chest or abdomen). For exam­ple, the biopsy might involve an initial thoracentesis (drainage of fluid in the chest) or paracentesis (drainage of fluid in the abdomen) and a pleural biopsy. These are relatively safe procedures that can be performed by a pulmonologist (lung physician), a radiologist, or a sur­geon. A local anesthetic (a numbing medicine such as lidocaine) is given to temporarily reduce the feeling in the area before the needle is inserted. Mesothelioma Cancer

Information from other sources on Mesothelioma Cancer

A pleural biopsy with a special needle may help in get­ting a diagnosis of mesothelioma, and it is generally performed by a pulmonologist. Since mesothelioma is usually diffuse (widely scattered) in the chest, a ran­dom sample of the pleura may give tissue with mesothelioma cells in it. A thoracentesis can be performed after the pleural biopsy is completed. The doctor inserts a needle into the pocket of fluid in the chest or abdomen to draw off some of the fluid. Many times, the needle is simply used to insert a flexible catheter (a tube the size of thin spaghetti) which is then used to draw off the fluid. After the fluid is drawn out through this catheter, the catheter is removed.

Our use of the term or terms Mesothelioma Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Mesothelioma Cancer visit our site often.

Mesothelioma Cancer

Posted in Cancer Lung Mesothelioma Asbestos | Tagged , |

Actos Warning Proclamation

By admin | Published January 26, 2012

Actos Warning : Tobacco smoking and occupational exposure have been the two major factors related to BC risk; however, not all smokers develop BC and not all cases of BC occurred in smokers or patients with chemical exposure. It has been proposed that there could be factors other than environmental that could affect the incidence on urothelial tumors. In fact, as for many other cancers, molecular researchers are trying to establish genetic alterations linked to carcinogenesis that could justify genetic predisposition.An important research has been conducted in patients with BC in relation to smoking and chemical exposure , trying to identify those patients with higher sus­ceptibility of being affected by environmental carcinogens. Aromatic amines were established carcinogens for urothelium.

 

More information on Actos Warning

They could be inactivated by acetylation pathway, and it has been postulated that those patients with slow acetylation capability were more susceptible to BC than those that are rapid acetylators. NAT-1 and NAT-2 are N-acetyltransferase genes located on the short arm of human chromosome 8 and they are involved in amines inactivation. Reduction in NAT-2 activity has been suggested as mechanism for BC predisposition among patients exposed to environmental carcinogens such as aromatic amines.A number of SNPs have been reported in NAT-2 coding exon, as well as over 35 NAT-2 haplotypes have been identified (Hein 2006). Several of these haplotypes corresponded to NAT-2 slow acetylator phenotype and NAT-2 slow acetylation genotype has been related to higher risk of BC.

Information from other sources on Actos Warning

The Spanish Bladder Cancer Study is a hospital-based case-control study on BC conducted in five different areas in Spain that included 1150 cases and 1149 controls. They evaluated in this great population the association of several polymorphisms in NAT and GST genes with BC risk and their interaction with cigarette smoking. In addition, they reported a metaanalysis of 29 studies of NAT-2 and BC including 5096 cases and 6519 controls. They demonstrated that NAT-2 slow acetylators had a 40% increase in BC risk compared to rapid/intermediate acetylators with an OR of 1.4 (95% CI, 1.2-1.7). They could also demonstrate a significant multiplication interaction between NAT-2 slow acetylation genotype and cigarette smoking, that is, NAT-2 slow acetylators were especially susceptible to the adverse effects of ciga­rette smoking on BC risk. On the other hand, the metaanalysis performed corrobo­rated their own data, being the summary on relative risk for NAT-2 slow acetylators compared to rapid/intermediate acetylators of 1.4 (Garcia-Closas et al. 2005).Other SNPs in different genes have been studied. Nucleotide excision repair (NER) pathway is a complex mechanism for repairing DNA damage and subse­quently for preventing carcinogenesis. NER pathway included several genes, and different SNPs on those genes have been related to an increase in BC risk. Twenty- two SNPs on seven NER genes were evaluated in 1150 cases and 1149 controls included in The Spanish Bladder Cancer Study. Four of these 22 SNPs in NER genes could be significantly related to a small increase in BC risk and interestingly it could be demonstrated as a stronger association between BC and polymorphism in ERCC2 gene (ERCC2 R156R) for never-smokers compared with ever-smokers (Garcia-Closas et al. 2006).

Other study including 696 patients with BC and 629 controls evaluated the asso­ciation with BC risk of a comprehensive panel of 44 SNPs in genes of NER path­way and genes involved in cell cycle control. They concluded that patients with higher numbers of variants in NER genes rather than single polymorphism are at increased risk for BC (Wu et al. 2006).

 

Our use of the term or terms Actos Warning is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Warning visit our site often.

http://www.seedol.com

Posted in Cancer Lung Mesothelioma Asbestos | Tagged , |

Actos and Bladder Cancer News Flash

By admin | Published January 26, 2012

Actos and Bladder Cancer : Traditionally, the surgery is performed through a lower abdominal incision in the midline from just below the umbilicus (i.e., “belly button”). Hospitalization for this procedure is generally between 5 and 10 days, and up to 6 weeks are needed for complete recovery. In recent years minimally invasive surgical approaches that replicate the technique of open radical cystectomy have been developed. Both laparoscopic and robotic-assisted radical cystectomies are currently being performed at highly specialized cen­ters. The principles of the surgery are the same, but the procedure is performed through smaller incisions using laparoscopic instruments. Using robotic assistance, your surgeon is able to perform complex operations with higher precision, under magnification. These approaches offer die potential advantage of a shorter recovery time, less blood loss, and less postoperative pain,

 

More information on Actos and Bladder Cancer

A pelvic lymph node dissection should be performed at the time of your surgery. This involves removal of the lymph node tissue in the most common areas of bladder cancer metastasis (spread of the cancer). The pelvic lymph node dissection has two important roles: to stage the cancer and to guide therapy. Individuals who are found to have cancer in the lymph nodes at the time of surgery generally require additional therapy such as chemotherapy. Studies have shown that up to 30 percent of patients with disease- positive lymph nodes who undergo a pelvic lymph node dissection will be free of disease at 5 years. Although there is debate among urologists as to exactiy how extensive ofapelvic lymph node dissection should be performed, there is no de­bate that one should be performed. Although a pelvic lymph node dissection can add an additional 30-90 minutes to your procedure time, there is little additional morbidity associ­ated when performed by an experienced surgeon.

 

Information from other sources on Actos and Bladder Cancer

Regardless of the approach, anyone who undergoes a radical cystectomy will require a form of urinary diversion because the bladder will no longer be there to store urine. This can have a significant psychological and functional impact on an individual’s quality of life. Patients are often hesitant to undergo definitive surgery because of the anxiety associated with long-term urinary diversion. There are two main types of urinary diversion: continent and noncontinent. Both forms require surgically removing a segment of bowel (most commonly the small bowel) from your gastrointestinal (GI) tract and plugging the ureter from each kidney into this segment of bowel to provide drainage of urine. Noncontinent diversions (ileal conduit) are those in which the piece of bowel is brought up through the abdominal wall to a stoma and the urine drains contin­uously into a drainage bag. This is die most common type of urinary diversion performed in the United States. This procedure requires approximately 8 to 10 centimeters (3 to 4 inches) of small bowel, which is far less than that used for continent urinary diversions. Although the obvious dis­advantage of this procedure is its lack of continence and need for a continuous drainage bag, it has less short- and long-term complications than that of the continent diver­sion. An external urinary drainage appliance is very well tolerated and patients adapt to them very quickly.

 

Our use of the term or terms Actos and Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos and Bladder Cancer visit our site often.

Actos and Bladder Cancer

Posted in Cancer Lung Mesothelioma Asbestos | Tagged , |

Carrier IQ Lawsuit Breaking News

By admin | Published January 26, 2012

Carrier IQ Lawsuit News – 1/25/2012 : In many countries, governments have discussed and proposed laws to regulate privacy protection and mechanisms to punish people and organizations that break the rules. Until privacy laws are really enforced, however, companies will find few incentives to protect and respect user privacy, mainly because most users don’t even realize that their privacy can be violated. A central problem is that behavior on the Web can’t be controlled. To regulate the Web, governments would have to regulate code writing or how Web applications (browsers, Java, e-mail systems, and so on ) function (Lessig, 1999). Also it is difficult to reach international consensus on Web privacy because the privacy concept is heavily dependent on widely variable cultural and political issues.

Later on U.S. government asked the Commerce Department to work with the Federal Trade Commission (FTC) to encourage organizations to implement self-regulatory practices. An FTC report in 2000, however concluded that U.S. self-regulatory approaches were ineffective in safeguarding consumer information, marketing techniques employed to profile customers were increasingly intrusive, and congressional legislative action was warranted to protect consumer privacy online (Electronic Privacy Information Center. The self-regulatory approach adopted by the U.S. is in direct contrast with the government-mandated approach adopted by the European Union (EU). Under the EU’s 1995, and subsequent 1997, Directive on Data Privacy, the burden is placed on companies and organizations—not individuals—to seek permission before using personal information for any purpose (Consumer International, 2003).

In July 2000, however, the United States negotiated a safe harbor agreement with the EU commission, wherein U.S. companies can voluntarily self-certify to adhere to a set of privacy principles loosely based on the fair information practices developed by the commerce department and the EU Commission. The primary difference under safe harbor is the ability of U.S. companies to administer self-enforcement by the European Commissioner or other agencies for compliance with the explicit rules of the EU directive (Consumer International, 2003). Although the United States recently passed new online privacy legislation, including the Childerns Online Privacy Protection Act (COPPA), Provisions in the Gramm-Leach-Bliley Financial Modernization Act (GLB) and the Health Insurance Portability and Accountability Act (HIPAA), these laws are applicable to relatively narrow types of information and particular industry sectors (Turner & Dasgupta, 2003).

For more information on Carrier IQ Lawsuit: follow us on our RSS Feeds.

The issue of who has control over personal data and how this data is used needs to be addressed at a global level in order for the Internet to develop into a trusted, widely acceptable international marketplace for the exchange of goods and services. The primary technology for collecting information on an individual’s activities over the Internet has been the Web “Cookie.” Cookies are digital information sent from a Web server and stored on the hard drive of an individual’s computer by the browser software or network application. Cookies were designed to address the problem of statelessness inherent in the Hypertext Transfer Protocol (HTTP) (Kristol, 2002). Because a browser does not stay connected to a server, but instead makes a connec­tion, sends its request, downloads the response, and makes a new connection to send another request, it severely limited the functionality ofWeb services and complicated application development. Web cookies provide a solution to this statelessness by allowing for continuity in the interaction between the browser and the Web server. The cookie has proven to be the most reliable, robust, and network friendly means to provide needed state functionality on the Web, although this functionality can also be provided by embedding state information in URLs, using hidden fields in HTML forms, or using the client’s IP address (Kristol, 2002).

Web bugs are hidden images that can be covertly added to any Web page; e-mail, or Microsoft Word, Excel, or PowerPoint file and used to collect information about user bahaviour. Web bugs send messages back to a server indicating its location, including the IP address of the computer, the URL of the page, the time the Web page or document was viewed, the type of browser used, and the previously set cookie value. Web bugs can also be used to determine if and when a Web page, e-mail message, or document is opened, the IP address of the recipient, and how often and to whom information is forwarded and opened (Harding, 2001).

Web bugs can also be used to associate a Web browser cookie to a particular e-mail address and read previously set cookie values. Thus, a source server with a very small or invisible window could be added to any Web site or Web-enabled file and used serendipitously for a variety of tracking, surveillance, and monitoring activities (Berghel, 2001). Monitoring browsing activities in and of itself is not considered by most Web users to be privacy invasive; however it is the ability to then link these activities back to an individual that has most consumers and privacy advocates alarmed (Turner & Dasgupta, 2003).

Information from other sources on Carrier IQ Lawsuit:

One of the first technologies available for protecting privacy on the Internet was the anonymizer. Anonymizers provide the ability to sanitize packet headers passed from the client to the server. Early versions consisted of software that would act like a proxy server, intercepting all communication between the browser and the server and removing all information about the requester. Current versions use Se­cure Socket Layers (SSL) technology for sending URL requests, establishing an encrypted communications tunnel between the user and the anonymizer proxy, and routing traffic through a number of proxy servers (Electronic Privacy Information Center, 1999).

This firewall- like technology disguises a user’s IP address, similar to most Internet service providers, and supplies with dynamic IP addresses every time they log on. Software tools are also available that provide a pseudonym proxy for logging on the Web sites, giving users consistent access to registration based systems without revealing personal data (Gabber, 1999). Web users can also install a filter, such as the one offered by Anonymizer. Filters are software programs that block cookies, banner advertisements and Web bugs. The disadvantage of filters is that they fail to consider consent; they block all cookies and thus users lose access to all personalized services, even those from the most trustworthy of sites. Also filters make privacy invasion difficult, but not impossible. A site can still identify users by IP address, interaction time, and geographical loca­tion, for example.

Given this users might need additional levels of privacy protection (Ishitani, 2003). These tool provide a means to protect the network identity of the computer; however, there are also negative performance and reliability consequen- ses. In addition, some specialized proxy servers can be used to intercept and alter information between client and server (Berghel, 2002). There are other technology-based solutions available for protecting privacy, includ­ing tools for filtering HTML allowing users to block certain URLs, anonymous re-mailers for sending and receiving e-mail messages, and software for managing Web cookies (Electronic Privacy Information Center, 1999).

Our use of the term or terms Carrier IQ Lawsuit: is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Carrier IQ Lawsuit: visit our site often.

Carrier IQ Lawsuit

Posted in Cancer Lung Mesothelioma Asbestos | Tagged , |

Actos Bladder Cancer Broadcast

By admin | Published January 26, 2012

Actos Bladder Cancer : Not resting on their laurels, the clinical research community has moved forward and is now testing a new combination that adds paclitaxel, another active drug mentioned above, to the gemcitabine- cisplatin regimen. A three-drug combination (gemcitabine-cisplatin- paclitaxel) has been compared to the two-drug standard, to see whether this produces better cancer shrinkage and improved survival. In June 2007, the first report of this trial was made public. It indicated that the three-drug combination offered no significant benefit compared to gemcitabine-cisplatin and was associated with more side effects.

Another new agent, pemetrexed, also targets the division and reproduction of cancer cells, and has a relatively gentle profile with regard to side effects. It is being tested in patients who have already been treated with gemcitabine and cisplatin to see whether it will cause tumor shrinkage. Early reports are promising, but its true use­fulness is not yet known, and it has not yet been assessed by the Food and Drug Administra tion, which must give formal approval for its use in the treatment of bladder cancer.

In addition to the use of chemotherapy, another class of anti-can- cer agents, the so-called growth inhibitors or targeted agents, is being tested in patients with advanced bladder cancer. It is known that pro­teins located on the surface of cancer cells can control the rate of DNA production and division and stimulate cancer-cell growth. An example is the epidermal growth factor receptor (EGFR), which sits on the surface of some bladder-cancer cells and helps to control the rate at which they grow and divide. Inhibitors of the function of EGFR (and of the genes that control its production) have been developed and are known to slow or stop the growth of some cancer cells.

More information on Actos Bladder Cancer

You may be alarmed if your doctor suggests the possibility of par­ticipating in a clinical trial Does it mean that you have no hope? What should you do? How should you respond? It’s important not to dismiss the idea out of hand. The words experimental, research, and human volunteer can be upsetting, particularly at a time when you are dealing with the emotional issues surrounding a diagnosis of advanced cancer. But treatments in clinical trials can often be highly beneficial to those who volunteer. You and your loved ones should talk with your medical team members about the kind of clinical trial they are recommending and why it may benefit you. In fact, several studies have shown that patients participating in clinical trials have better outcomes than those found in the community at large. However, this also may be due to the types of patients who agree to participate in trials.

Does referral to a clinical trial mean that there is no hope of your surviving this illness? Not at all! There is always hope of survival, and any doctor can tell you about people who have responded positively to treatment and not only survived, but thrived. Being in a clinical trial doesn’t mean that you won’t continue to receive medical treatment; you wall, and since it’s a voluntary process, you have the right to stop participating in the trial at any time.

As with any aspect of your treatment plan, you make the decision about whether to proceed. Don’t feel pressured to participate in a trial if it doesn’t feel right for you, but do give it objective thought and consideration. How do you begin thinking through the decision on whether to participate in a trial?

Information from other sources on Actos Bladder Cancer

Probably the first question that comes to your mind is whether clinical trials are safe. Scientists and medical investigators work hard to ensure that they are as safe as possible. The medical community and the U.S. Department of Health and Human Sendees have put rules in place ensuring that every clinical trial is highly regulated and reviewed by health-care professionals, who determine that the trial is designed and conducted in compliance with federal regulations gov­erning research on human volunteers. Everything about the trial, from the doctors involved to the people who volunteer and the treat­ment being tested, is subject to strict review and monitoring. However, it is important to understand that some clinical trials do carry increased risks.

As with any treatment, you’ll want to ask about possible risks, ben­efits, side effects, how the treatment works, and what results doctors expect from the study.You’ll want to know who is conducting the clin­ical trial and what kind of oversight is in place. Also ask what is expected of you. Where will you go for the treatments? How often will you go? Are there more tests or office visits than you might have with standard treatment? Who administers the treatments and how are the results measured? Do you have to report regularly to those running the trial? Who pays for it all? Will there be extra costs to you as a result of your participation? Will the team conducting the trial (or the doctors involved) stand to benefit personally from the results of the trial or its conduct?

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

Actos Bladder Cancer

Posted in Cancer Lung Mesothelioma Asbestos | Tagged , |

Mesothelioma Lawyers Information

By admin | Published January 26, 2012

Mesothelioma Lawyers : The fluid and the tissue from the pleural biopsy will be sent to a pathologist and/or cytologist who will look under the microscope at the cells and determine whether mesothelioma is present. In the past, a diag­nosis of mesothelioma from fluid alone was possible only a third of the time because of the difficulty of distinguishing between reactive or noncancerous cells and tumor cells. By staining the fluid with a special substance, pathologists can now make a diagnosis more easily. Your doctor will refer to these stains as “immunos,” short for immunohistochemistry. You should make sure that any material used in the biopsy has been studied using these immuno stains. A chest x-ray is always performed after these procedures to make sure there were no complications from the biopsies, such as an accumulation of air in the chest (pneumothorax). The chest x-ray is also very important to see whether the majority of the fluid has been removed and if the lung is now able to expand with air and fill the chest cavity as it normally should. Mesothelioma Lawyers

For more information on Mesothelioma Lawyers follow us on our RSS Feeds.

More-invasive testing may be needed if the initial results of the semi-invasive tests do not provide ade­quate information or if the CT scan indicates that it would be difficult to do the semi-invasive tests. The latter situation would occur if the fluid is not free flow­ing but is hidden in pockets that are difficult to reach. In such cases, it is better to inspect the chest directly to find out where to do the biopsy. A thoracoscopy (the use of a lighted scope, with or without a camera, to look into the chest) is performed in patients who are at risk for mesothelioma and who develop a large fluid accumulation, with or without associated solid tumor masses in the chest. In patients who are at risk for mesothelioma but whose thoracentesis does not reveal cancer cells, or who experience a recurrence of fluid after the initial thoracentesis is performed, a thora­coscopy should probably be performed. This procedure involves using a special lighted instrument called a thoracoscope to look inside the chest cavity. The scope is placed into the chest between two ribs after a small (1-inch) cut is made through the chest wall. If the doctor finds any tissue that looks abnormal, he or she will cut out a piece, or biopsy a piece, of it to have it looked at under the microscope. This tissue will then be examined for cancer cells. Mesothelioma Lawyers

Information from other sources on Mesothelioma Lawyers

Lastly, if the radiologic tests indicate that there is more solid tumor than fluid, or if there is no longer a space where fluid can accumulate because of previous attempts to control the fluid, an “open” biopsy may be indicated. The incision does not have to be large if the pleura is thickened, but the procedure should be per­formed by a thoracic surgeon who understands the principles of mesothelioma treatment. This surgeon will usually suggest a 3- or 4-inch incision on the side of the chest, overlying an area of pleura that is thickened. The surgeon may or may not remove a small piece of rib at this site to allow a direct view of the thickened pleura. Many times, a good-sized piece of pleura (1 to 1 1/2 inches in diameter) can be removed at this site. Getting a quick freeze of the tis­sue in the operating room, with the pathologist look­ing at the biopsy, will ensure that there’s enough tissue to perform all the required testing and to make a diagnosis. Surgeons performing these biopsies should pick the right place for the biopsy, and the cut (inci­sion) for this biopsy should be in line with the longer incision that would be used later if the patient is a surgical candidate. That way, this shorter incision can be removed.

Our use of the term or terms Mesothelioma Lawyers is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Mesothelioma Lawyers visit our site often.

Mesothelioma Lawyers

Posted in Cancer Lung Mesothelioma Asbestos | Tagged , |

Actos Side Effects News

By admin | Published January 26, 2012

Actos Side Effects : CAN CYTOLOGY BE USED INSTEAD OF CYSTOSCOPY TO RULE OUT BLADDER CANCER?

Urinary cytology is the examination of urine using special stains to look for cancer cells. These cells would have been those that have broken off (exfoliated) from the lining of the urinary tract. Voided urine is sent for analysis. First voided morning urine should not be used as there is a higher rate of cellular degeneration. To enhance the yield of cells, the bladder can be barbotaged (flushed). Cytology is most useful for high grade or aggressive tumors and for those with carcinoma in situ (CIS). In low to intermediate grade tumors, cytology may not be positive because these tumors may not exfoliate cells into the urine. In addition, if low grade tumor cells are exfoliated, they may appear to the pathologist to be identical to normal bladder cells. Due to the limitations of sensitivity of cytology, it is not a very good screening test, but proves to be valuable in following some individuals who have already been diagnosed and treated for bladder cancer.

Because a positive cytology is very specific for cancer, it is highly predictive of transitional cell cancer even if no tumor is visible during cystoscopy. Additional information can be obtained with urine cytology. The DNA content and measurement of the amount of abnormal DNA can be determined. In general, as the amount of abnormal DNA is increased, the prognosis is worsened.

More information on Actos Side Effects

ARE THERE ANY OTHER URINE TESTS THAT ARE HELPFUL IN MAKING THE DIAGNOSIS?

There has been continued research and a subsequent array of urine tests to screen for bladder cancer. Some of these newer tests include:

Bladder Tumor Antigen (BTA): measures basement membrane protein antigen released into the urine, a protein from the bladder wall.

NMP22: measures nuclear matrix protein 22

Aura Teck FDP: measures fibrin, fibrinogen degradation

products

Telomerase: measures the enzyme used to preserve telomeres (the ends of chromosomes required to continue cell division) Hyaluronic Acid, Hyaluronidase: substances which have a role in blood vessel growth in bladder tumors and tumor progression. [1] Research goes on and newer tests may prove to be both more sensitive (positive if cancer is present) and more specific (not positive for other reasons). At this time, none of the urine tests are sensitive enough to take the place of cystoscopy in the initial evaluation of an individual suspected to have bladder cancer. In general, cytology as an adjunct to cystoscopy is more helpful than any of the urine bladder cancer tests to date.

AS PART OF MY INITIAL WORK UP, MY PHYSICIAN HAS ORDERED A CAT SCAN. WHAT’S THE PURPOSE AND ARE THERE ANY ALTERNATIVES?

When an individual has gross hematuria or persistent microscopic hematuria, a complete assessment of the urinary tract is required. Although cystoscopy is the test of choice for examination of the bladder, imaging studies are required to make sure there is no disease in the upper tracts (kidneys and ureters). Bleeding can be caused from many different disorders including transitional cell carcinoma of the upper tracts, kidney or ureteral stones, or renal cell carcinoma (cancer of the parenchyma or fleshy part of the kidneys). Your urologist has a number of options to choose from. There are advantages and disadvantages of each.

Intravenous pyelogram (IVP) is accomplished by injecting a contrast agent into your vein and then obtaining X ray images. The contrast is excreted by your kidneys, subsequently filling the lumen of the kidneys, ureters and the bladder. The contrast allows one to see subtle filling defects within chambers of the urinary tract, possibly representing tumor, stone or blood clot. Tumors of the fleshy part of the kidneys can also be seen. The study also allows for an assessment of renal function. It is a sensitive test for renal obstruction, which can occur because of cancer. Disadvantages of the study include the possibility of an IV contrast agent allergy, which occasionally may be serious.

You will be asked whether you have a sea food allergy, a known allergy to iodine or to IV contrast. If this is the case, you may need to be premedicated prior to the exam to avoid a reaction. Although the study is quite useful at visualizing the upper tracts, it is not very good at picking up subtle tumors on the bladder surface. If your kidneys do not function well (you have renal insufficiency), the contrast may cause harm to your kidneys and the imaging will not be as good. For pregnant women, any X ray exam could be potentially damaging to the fetus and therefore, will not be performed.

 

Information from other sources on Actos Side Effects

Ultrasonography can check for a kidney tumor, stone, or obstruction. Bladders filled with urine can be scanned. There is no contrast or X rays involved, and therefore the study can be accomplished in those with renal disease, contrast allergies or for women who are pregnant. Although larger tumors of the bladder are often visible, it is not a good study to rule out urothelial cancer (transitional cell cancer of the urinary tract lining) since smaller tumors or flat tumors in the lining are not visible. Also, other conditions such as enlarged folds in the bladder or enlarged prostates can be confused with bladder tumors. Ultrasound exams are generally fast, painless, and relatively inexpensive. An ultrasound combined with cystoscopy plus cytology (to rule out cancer cells) is a reasonable assessment for those with a low likelihood of having upper tract disease.

CT Scan or CAT (computerized axial tomography) provides a computerized cross sectional visualization of the abdomen and pelvis. X ray images are synthesized into exquisitely detailed images. The CT scan can be done with or without IV contrast, and therefore has the same limitations as IVP in those with allergies to contrast or renal insufficiency. These studies are excellent for finding renal cell cancers and stones within the kidneys and ureter, but not very good at delineating cancers of the lining. CT scan is often an important part of staging bladder cancer, determining whether the cancer has spread.

Magnetic Resonance Imaging (MRI) is a technology which uses strong magnets to provide detailed images of your internal organs. Like ultrasound, this study has no known harmful effects on the body. It does not require contrast injection like CT scan and can be done safely in patients with renal insufficiency. It is not generally used for initial screening. Many individuals find the test uncomfortable due to a loud noise heard throughout the test, in addition to the close quarters the machine requires, leading to feelings of claustrophobia. A mild sedative may be required if the test is necessary and the individual experiences these uncomfortable feelings.

Our use of the term or terms Actos Side Effects is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Side Effects visit our site often.

Actos Side Effects

Posted in Cancer Lung Mesothelioma Asbestos | Tagged , |

Cell Phone Privacy Lawsuit Broadcast

By admin | Published January 26, 2012

Cell Phone Privacy Lawsuit News- 1/25/2012: At first it may sound like a stretch to claim that technology has the potential to shape the way we think about other things in life. After all, many of us have been led to believe that technology has no real power in itself and that it’s how people use technology that matters. Neil Postman wrote a book titled Technopoly: The Surrender of Culture to Technology,9 in which he explains how using technology leads us to think of everything in technological terms. According to Postman, human beings have a need to fit the pieces of their lives into something that gives the impression of coherence, and the technologies themselves structure our interests. That’s why we often seek technological solutions to technological ques­tions and why we often reach for more technology to solve the problems caused by present technologies. We may not be consciously aware of the many ways in which technology structures our thoughts, but at the unconscious level, the same characteristics that are inherent in the technology begin to creep into our daily practices. This affects both our behavior and attitudes, but also our as­sumptions and expectations. Throughout the twentieth century, American society embraced the belief that technology equaled progress and that if we could get technology into the hands of more people, we could all participate in the great American Dream of consuming products and enjoying better, more comfortable lives.

. Cell phones are useful tools to let someone know you’re running late for a meeting, but they often are used to cover poor planning or inconsiderate actions. These wonderful inventions have done so much to liberate us from traditional ways of working or communicating with friends or family, but we often are unaware of the “speed-up” in our lives. We tend to be working more, playing less, and finding that by being always connected by phone or computer to responsibilities and obligations, our stress levels increase, rather than decrease. The technologies make it easer to react in moments, but at the same time, we can speed through tasks and ignore thinking about their consequences or their quality. It’s hard to relax when the constant barrage of messages demands our attention. Like Pavlov’s dog, we become conditioned to respond immediately to electronic messages. Our nerves and senses become keenly attuned, we viscerally need to respond, and we therefore contribute to the constant hum of information and message flow and exchange. People who jump to grab their cell phones when one rings in a public place, even if it isn’t their own phone, know about this type of conditioning. Most people answer e-mail sequentially, and if they think they’ll go back to a previous message, the message is easily forgotten. These people understand the way the technology is controlling them, too—especially when someone screams, “Didn’t you get my e-mail?”

For more information on Cell Phone Privacy Lawsuit: follow us on our RSS Feeds.

Whether people use cell phones and the Internet at work, in public, or for personal reasons also contributes to how “connected” they feel to other people and to their daily obligations. The portable features of cell phones and the ease of accessing the Internet in public places or over the cell phone influences peoples’ attitudes and behaviors about where they can go and still remain productive. When people can be contacted wherever they are, the distinctions between personal time and obligations to work, family, or friends can seem endless. We might feel that we have greater control over our time, but the urge to be constantly in touch with others can be so stressful that consciously or unconsciously, we begin to think in Luddite terms.10 After all, people might find it more comfortable to work from home and more convenient to buy things over the Internet, and it may be more reassuring to know that we can reach a loved one at any time of day or night, but at the same time we become primed for responding to the cell phone’s ring or the computer’s audio cue that something just arrived, and we may feel that whatever the message, it needs immediate attention.

Many people justify the use of these technologies by claiming that the con­veniences outweigh the annoyance of listening to someone else’s phone ring, or overhearing a private conversation in a public place, or feeling oppressed by e­mails that need answering. Using cell phones and the Internet in different places creates competition for attention and focus. The portability and small size of a cell phone allows people to shift attention to the technology rather than paying attention in some environments that are structured to allow a person to focus on an activity. Evidence shows that when we use a cell phone in a car, our attention is not necessarily on our driving, and accidents can occur. Personal conversations are often interrupted while someone answers a cell phone call, to the annoyance of the other person in the conversation, who feels less important in the personal interaction. Technologically savvy teens are adept at text messaging, game playing, and downloading free content, but they often do this while in class or some other inappropriate place, much to the consternation of their teachers. The intersection of the positive and negative aspects of technology results in a change in values— how we think about what we do, and how we reach a feeling of satisfaction or contentment with our present lives, or not.

Information from other sources on Cell Phone Privacy Lawsuit:

Would we use cell phones and the Internet so readily if they didn’t fit a con­temporary lifestyle that attempts to pack more organizational productivity into every day? Do cell phones and the Internet really contribute to a feeling that we can control more aspects of our social environments? Few would disagree that the pace of American life has accelerated throughout the twentieth century, but how convincing is the argument that technology has contributed to this feeling of faster-paced lifestyles? It would be difficult to mount an argument that the faster pace of life is the result of cell phones and the Internet, but these technologies are undoubtedly components of the type of social change that Americans have experienced in recent years, particularly as instant communication has become more of a factor in social life. The rise of the wired communication system in the late 1800s (the long revolution) and the mobility afforded by cell phones and the Internet (the short revolution) are tied to what is specifically a question of lifestyle in the United States.

Our use of the term or terms Cell Phone Privacy Lawsuit: is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Cell Phone Privacy Lawsuit: visit our site often.

Cell Phone Privacy Lawsuit

Posted in Cancer Lung Mesothelioma Asbestos | Tagged , |

Actos Side Effects Information

By admin | Published January 25, 2012

Actos Side Effects : More information on Actos Side Effects

MY FAMILY WANTS ME TO GO FOR TREATMENT OF MY BLADDER CANCER TO THE “TEACHING HOSPITAL” IN THE CITY MY LOCAL UROLOGIST IS COMPETENT AND CARING AND I TRUST HIS JUDGEMENT SHOULD I LISTEN TO MY FAMILY AND SWITCH UROLOGISTS?

As we have discussed in the preceding questions, finding an excellent urologist to partner with is a must. A physician established at a “teaching hospital” (a hospital where physicians are trained in their respective fields of specialty) is at the minimum, competent. A large teaching or academic center would not risk its reputation on an individual who is sub par. Some individuals may be world class surgeons, but not all will be. An individual may be an average surgeon, but a gifted teacher or researcher, making them invaluable to their academic center. Your local community urologist will likely be an individual trained at one of these academic teaching hospitals. In addition, community hospitals also have credentialing and quality review programs to weed out incompetent physicians. In general, it is true the academic center will have more stringent standards and review of their staff. Nevertheless, excellent physicians can be found at the community hospital as well.

ISN’T IT TRUE THAT ACADEMIC OR TEACHING HOSPITALS WILL HAVE THE BEST TECHNOLOGY OR MOST UP TO DATE INFORMATION TO TREAT MY CANCER?

These hospitals generally are at the forefront of innovation regarding technological advances, testing and implementation of new surgical techniques and chemotherapeutic regimens. However, no one center can be excellent in all spheres of medicine. Each will have particular strengths and weaknesses. We are however, fortunate medical knowledge and innovation are shared openly via medical journals and conferences and other means of information exchange. New information and proven effective techniques are rapidly disseminated throughout the medical community. Some teaching hospitals may be “centers of excellence” for a particular procedure or innovative approach that is available at only a few sites in the country. There is naturally a lag time for some procedures to spread to the local level, and if in fact a new procedure carries substantial benefits compared to the standard, and is not available locally, then a referral may be appropriate.

Medical information is scrutinized in journals and reviewed at conferences. The newest treatment regimens for advanced cancer are explored in clinical trials to determine their efficacy and safety. It is only after they are proven that they become adopted as standard practice by most physicians. For the vast majority of individuals with bladder cancer, excellent, comprehensive treatment can be obtained at the local level. For those requiring more specialized care or for those unfortunate individuals with advanced cancer who desire experimental therapy via a clinical trial for their cancer, a referral to the appropriate center may be appropriate.

IF I HAVE MY MAJOR SURGERY PERFORMED AT A TEACHING HOSPITAL, WILL THE ATTENDING PHYSICIAN PERFORM MY SURGERY AND TAKE CARE OF ME AFTERWARDS?

At a teaching hospital, physicians are in training to master their skills before going out into “practice” in their respective fields. Interns are fresh out of medical school with limited practical training. Often they are referred to as PGY 1 (post graduate year 1). Years of training follow (PGY2, PGY3 etc.). Urology residents are required to generally have at least two years of training in a surgical program followed by four years in urology residency. It is the responsibility of the residency director to provide adequate training for these future urologists while assuring patient safety. Practically speaking, there are usually one or more attending physicians who supervise the work of the physicians in training. The attending physicians are board certified, experienced physicians who treat patients while simultaneously training physicians. The residents will be a key component in your care. They will be assessing you both pre- and post-operatively and will be writing orders directing your care. How much of the surgery they get to do is dependent on their years of training and their skills. They will be under the direct supervision of the attending physician. If you have concerns, you should address them with your attending physician.

MY UROLOGIST ALWAYS KEEPS ME WAITING, DOES THIS MEAN HE DOESN’T CARE?

Given the monetary pressures in today’s medical practice, some physicians are over booked and cannot see the allotted number of patients scheduled without delays. The theory behind this schedule is the expectation that a number of patients will not show for their appointment, allowing the physician to stay true to the schedule and not fall behind.

However, sometimes all of the patients do show, and the physician is delayed. Even with a carefully thought out schedule, emergencies may arise and some visits unexpectedly take longer than scheduled. The physician wants to devote the time and attention required for each individual. After all, you also expect the same time and attention during your visit. Even the most conscientious physician may find himself running behind in a busy medical practice. This lateness should be recognized by the physician who will often acknowledge it with an apology. If you find it distressing to wait more than fifteen minutes (a reasonable time to wait), you should discuss your feelings with your physician, who often can arrange an appointment at the beginning of the schedule when he will almost be guaranteed to be on time.

WILL THERE BE OTHER PHYSICIANS INVOLVED IN MY TREATMENT OF BLADDER CANCER?

You may need to be referred to an oncologist, a physician specialist in the medical therapy of cancer. At times, a referral to a radiation oncologist, a specialist who treats cancer with radiation, may be required. Other individuals may need to be consulted as well. It is important for your urologist to keep your primary care physician up to date so that he can coordinate your care and if required by your insurance plan, make the appropriate referrals.

Information from other sources on Actos Side Effects

On a regular basis, magazine articles, books, and television shows implore those with major illnesses to seek out a second opinion. The general consensus is there is much to be gained and little to be lost, so why not seek out a second opinion? The issue certainly is more complicated than generally addressed, and deserves a review. The following chapter provides a second opinion on second opinions.

WHAT ABOUT SECOND OPINIONS?

In general, a competent physician will recommend a second opinion if there is uncertainty regarding your care. This uncertainty could involve the pathology report or debate regarding the most appropriate treatment options. Certainly if the pathology report is in question, a second opinion is mandatory! Your urologist should be able to spell out his treatment plans for you, what to expect and what alternatives may be required, depending on the seriousness of your disease. The plan may change over time as your disease improves or worsens.

You may need a second opinion if you are not doing well and your physician is unable to provide satisfactory explanations and solutions. Occasionally, your urologist may recommend a second opinion if your problem is unusual or particularly complicated. Having a physician you can trust is mandatory when dealing with cancer. Don’t let anyone pressure you into a second opinion if you feel confident in your physician’s abilities. On the other hand, if you are uncomfortable with your progress or a treatment recommendation, if you are not satisfied with the explanations given to you, don’t hesitate to seek out a second opinion. Your urologist should not feel threatened by this request as he wants you to feel comfortable with the plan of action. Only by partnering with your physician can he be most effective.

WILL MY UROLOGIST BE UPSET WHEN I REQUEST A SECOND OPINION?

Many physicians may feel slighted when a patient requests a second opinion. Your urologist may feel somehow you don’t trust his explanations, skill, or judgment. On the other hand, when a new patient faces a difficult or unexpected diagnosis, the urologist may find the request not at all unusual. It is important you explain to your urologist why you feel a second opinion is warranted. Urologists are professionals and will graciously facilitate your request. The experienced urologist comes to realize that despite his best efforts, some patients will seek a second opinion. If a patient is particularly concerned or nervous about a proposed treatment regimen, your urologist may welcome your request. Your urologist should facilitate your second opinion by sending appropriate records and telling you whether or not it is necessary for you to bring X rays or pathology slides with you. Your primary care physician may need to be contacted for the referral if your insurance requires it.

WHY DOESN’T MY UROLOGIST WANT ME TO GO FOR A SECOND OPINION?

Often, the urologist may believe the second opinion is unnecessary and will delay treatment. He may be concerned you will not only have a second opinion, but transfer your future care to the urologist providing the second opinion. He may believe that you may get bad advice. It is possible he may feel threatened the next urologist will not agree with his work up or care of you to date.

WHERE DO I FIND A SPECIALIST FOR A SECOND OPINION?

Start by asking your primary care physician. You may be able to see another urologist in your community. Do not see another urologist in the same group as a conflict of interest may deter a different opinion. If you are considering a different course of action, such as radiation or chemotherapy, a referral to the appropriate specialist should be made.

Many times your urologist will be highly supportive and suggest a second opinion. He will offer his recommendations and facilitate your visit to the appropriate physician. If there is an issue regarding the care given at your local hospital, you may wish a referral to a “tertiary” or teaching hospital. In most areas, a referral for this reason is unnecessary, as excellent care is obtainable in the community hospital.

 

Our use of the term or terms Actos Side Effects is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Side Effects visit our site often.

http://www.seedol.com

Posted in Cancer Lung Mesothelioma Asbestos | Tagged , |